Data from Targeting AEBP1 to Mitigate Protumor Activity of Cancer-Associated Fibroblasts and Increase Therapeutic Efficacy of Anti–PD-1
Suchitra Natarajan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xin Yu(Jiangnan University), Elysia C. Saputra(Merck & Co., Inc., Rahway, NJ, USA (United States)), Khoa Dang P. Nguyen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Heyuan Li, Ling Li, Hong Sun, Cindy Li, Gukhan Kim, Wendy M. Blumenschein, Muhammad Afham Ramli, Yu Liu, Aleksandra Olow(Amgen (United States)), Dewan Hossain, William J. Monis
Cited by 0
Related Papers
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
|Nature Immunology|2008|1.5k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k
Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires <i>cis-trans</i> receptor clustering
|Proceedings of the National Academy of Sciences|2012|213